• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低收入和中低收入国家的克罗恩病:一项范围综述

Crohn's disease in low and lower-middle income countries: A scoping review.

作者信息

Rajbhandari Ruma, Blakemore Samantha, Gupta Neil, Adler Alma J, Noble Christopher Allen, Mannan Sara, Nikolli Klejda, Yih Alison, Joshi Sameer, Bukhman Gene

机构信息

Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, United States.

Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA 02199, United States.

出版信息

World J Gastroenterol. 2020 Nov 21;26(43):6891-6908. doi: 10.3748/wjg.v26.i43.6891.

DOI:10.3748/wjg.v26.i43.6891
PMID:33268969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7684456/
Abstract

BACKGROUND

While Crohn's disease has been studied extensively in high-income countries, its epidemiology and care in low and lower-middle income countries (LLMICs) is not well established due to a lack of disease registries and diagnostic capacity.

AIM

To describe the published burden, diagnostic/treatment capacity, service utilization, challenges/barriers to individuals with Crohn's in LLMICs and their providers.

METHODS

We conducted a scoping review utilizing a full search strategy was developed and conducted in PubMed, Embase and World Health Organization Global Index Medicus. Two independent reviewers screened the titles and abstracts of all of the publications found in this search, reviewed selected publications, and extracted relevant data, which underwent descriptive review and was analyzed in Excel.

RESULTS

The database search yielded 4486 publications, 216 of which were determined to be relevant to the research questions. Of all 79 LLMICs, only 21 (26.6%) have publications describing individuals with Crohn's. Overall, the highest number of studies came from India, followed by Tunisia, and Egypt. The mean number of Crohn's patients reported per study is 57.84 and the median is 22, with a wide range from one to 980.

CONCLUSION

This scoping review has shown that, although there is a severe lack of population-based data about Crohn's in LLMICs, there is a signal of Crohn's in these settings around the world.

摘要

背景

虽然克罗恩病在高收入国家已得到广泛研究,但由于缺乏疾病登记和诊断能力,其在低收入和中低收入国家(LLMICs)的流行病学和医疗情况尚未明确。

目的

描述已发表的关于LLMICs中克罗恩病患者及其医疗服务提供者的疾病负担、诊断/治疗能力、服务利用情况、挑战/障碍。

方法

我们采用全面检索策略进行了一项范围综述,检索了PubMed、Embase和世界卫生组织全球医学索引。两名独立评审员筛选了该检索中找到的所有出版物的标题和摘要,审查了选定的出版物,并提取了相关数据,这些数据经过描述性综述并在Excel中进行分析。

结果

数据库检索产生了4486篇出版物,其中216篇被确定与研究问题相关。在所有79个LLMICs中,只有21个(26.6%)有描述克罗恩病患者的出版物。总体而言,研究数量最多的来自印度,其次是突尼斯和埃及。每项研究报告的克罗恩病患者平均数量为57.84,中位数为22,范围从1到980不等。

结论

这项范围综述表明,尽管LLMICs严重缺乏基于人群的克罗恩病数据,但全球这些地区存在克罗恩病的迹象。

相似文献

1
Crohn's disease in low and lower-middle income countries: A scoping review.低收入和中低收入国家的克罗恩病:一项范围综述
World J Gastroenterol. 2020 Nov 21;26(43):6891-6908. doi: 10.3748/wjg.v26.i43.6891.
2
Crohn's Disease Among the Poorest Billion: Burden of Crohn's Disease in Low- and Lower-Middle-Income Countries.最贫困的十亿人中的克罗恩病:中低收入国家的克罗恩病负担。
Dig Dis Sci. 2023 Apr;68(4):1226-1236. doi: 10.1007/s10620-022-07675-6. Epub 2022 Aug 31.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Enteral nutritional therapy for inducing remission of Crohn's disease.诱导克罗恩病缓解的肠内营养疗法。
Cochrane Database Syst Rev. 2001(3):CD000542. doi: 10.1002/14651858.CD000542.
5
Enteral nutritional therapy for induction of remission in Crohn's disease.肠内营养疗法诱导克罗恩病缓解
Cochrane Database Syst Rev. 2007 Jan 24(1):CD000542. doi: 10.1002/14651858.CD000542.pub2.
6
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
7
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.
8
Cyclosporine for induction of remission in Crohn's disease.环孢素用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2005 Apr 18(2):CD000297. doi: 10.1002/14651858.CD000297.pub2.
9
Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.用于识别克罗恩病高危人群的预后工具:系统评价和成本效益研究。
Health Technol Assess. 2021 Mar;25(23):1-138. doi: 10.3310/hta25230.
10
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2006 Jul 19(3):CD006097. doi: 10.1002/14651858.CD006097.

引用本文的文献

1
Efficacy of High-Dose Methylprednisolone in Inducing Remission in Pediatric Acute Severe Ulcerative Colitis: Retrospective Study.大剂量甲泼尼龙诱导小儿急性重症溃疡性结肠炎缓解的疗效:回顾性研究
J Clin Med. 2025 Jul 12;14(14):4938. doi: 10.3390/jcm14144938.
2
Investigating the Impact of hsa_circ_0005255 on Proliferation and Autophagy in Crohn's Disease Intestinal Epithelial Cells Through miR-23a-3p-Mediated NCOA3 Expression.通过miR-23a-3p介导的NCOA3表达研究hsa_circ_0005255对克罗恩病肠上皮细胞增殖和自噬的影响
Kaohsiung J Med Sci. 2025 Aug;41(8):e70035. doi: 10.1002/kjm2.70035. Epub 2025 May 7.
3
The current state of pediatric gastroenterology in under-resourced nations.

本文引用的文献

1
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年炎症性肠病的全球、区域和国家负担:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30. doi: 10.1016/S2468-1253(19)30333-4. Epub 2019 Oct 21.
2
Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review.拉丁美洲和加勒比地区炎症性肠病的进展:系统评价。
Clin Gastroenterol Hepatol. 2020 Feb;18(2):304-312. doi: 10.1016/j.cgh.2019.06.030. Epub 2019 Jun 25.
3
资源匮乏国家小儿胃肠病学的现状。
Ann Med Surg (Lond). 2025 Mar 7;87(4):2218-2228. doi: 10.1097/MS9.0000000000003141. eCollection 2025 Apr.
4
Inflammatory bowel disease: a narrative review of disease evolution in South Asia and India over the last decade.炎症性肠病:过去十年南亚和印度疾病演变的叙述性综述
Therap Adv Gastroenterol. 2024 Nov 20;17:17562848241258360. doi: 10.1177/17562848241258360. eCollection 2024.
5
Extracorporeal Photopheresis with 5-Aminolevulinic Acid in Crohn's Disease-A First-in-Human Phase I/II Study.5-氨基酮戊酸体外光化学疗法治疗克罗恩病——一项首例人体I/II期研究
J Clin Med. 2024 Oct 17;13(20):6198. doi: 10.3390/jcm13206198.
6
Crohn's Disease Previously Mistreated as Intestinal Tuberculosis Complicated with Ileocecal Lump: A Case Report.曾被误诊为肠结核合并回盲部肿块的克罗恩病:一例报告
JNMA J Nepal Med Assoc. 2024 Mar 31;62(272):275-278. doi: 10.31729/jnma.8534.
7
Strategies for Enhancing Inflammatory Bowel Disease Care in Pakistan: Bridging Gaps and Building Capacities.加强巴基斯坦炎症性肠病护理的策略:弥合差距与建设能力
Crohns Colitis 360. 2024 Apr 22;6(2):otae027. doi: 10.1093/crocol/otae027. eCollection 2024 Apr.
8
Evaluation of Factors Contributing to Diagnosis of Crohn's Disease in the Face of Increasing Trend in Pakistan.巴基斯坦克罗恩病诊断相关因素评估:面对发病率上升趋势的研究
Crohns Colitis 360. 2024 Mar 22;6(1):otae015. doi: 10.1093/crocol/otae015. eCollection 2024 Jan.
9
Increasing ratio of opportunistic infections associated with sunshine exposure and economic level burdening Chinese inflammatory bowel disease hospitalized patients: the first nationwide survey from 2014 to 2019.与阳光暴露和经济水平相关的机会性感染在增加,给中国炎症性肠病住院患者带来负担:2014 年至 2019 年的首次全国性调查。
BMC Public Health. 2024 Jan 9;24(1):133. doi: 10.1186/s12889-024-17635-6.
10
Engineered calprotectin-sensing probiotics for IBD surveillance in humans.用于人类 IBD 监测的工程化钙卫蛋白感应益生菌。
Proc Natl Acad Sci U S A. 2023 Aug 8;120(32):e2221121120. doi: 10.1073/pnas.2221121120. Epub 2023 Jul 31.
Crohn's disease in a developing African mission hospital: a case report.
一家非洲发展中传教医院的克罗恩病:病例报告
J Med Case Rep. 2019 Mar 7;13(1):80. doi: 10.1186/s13256-019-1971-5.
4
Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study.阿达木单抗生物类似药在炎症性肠病中的有效性和安全性:一项多中心研究。
Indian J Gastroenterol. 2019 Feb;38(1):44-54. doi: 10.1007/s12664-018-0922-1. Epub 2019 Jan 15.
5
Epidemiology and clinical course of inflammatory bowel disease in the Central Province of Sri Lanka: A hospital-based study.斯里兰卡中部省份炎症性肠病的流行病学与临床病程:一项基于医院的研究。
JGH Open. 2018 Jun 6;2(4):129-133. doi: 10.1002/jgh3.12058. eCollection 2018 Aug.
6
Low FODMAP diet in Egyptian patients with Crohn's disease in remission phase with functional gastrointestinal symptoms.低FODMAP饮食对处于缓解期且伴有功能性胃肠道症状的埃及克罗恩病患者的影响
JGH Open. 2018 Feb 5;2(1):15-20. doi: 10.1002/jgh3.12037. eCollection 2018 Feb.
7
Impact of dietary beliefs and practices on patients with inflammatory bowel disease: An observational study from India.饮食观念和习惯对炎症性肠病患者的影响:一项来自印度的观察性研究。
JGH Open. 2017 Sep 18;1(1):15-21. doi: 10.1002/jgh3.12002. eCollection 2017 Sep.
8
Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific.人群密度与炎症性肠病风险:亚太地区 13 个国家或地区的前瞻性人群研究
Am J Gastroenterol. 2019 Jan;114(1):107-115. doi: 10.1038/s41395-018-0233-2.
9
Risk factors for inflammatory bowel disease: A prospective multi-center study.炎症性肠病的风险因素:一项前瞻性多中心研究。
Indian J Gastroenterol. 2018 May;37(3):189-195. doi: 10.1007/s12664-018-0850-0. Epub 2018 Jul 9.
10
The prevalence and phenotype in Brazilian patients with inflammatory bowel disease.巴西炎症性肠病患者的患病率及表型
BMC Gastroenterol. 2018 Jun 18;18(1):87. doi: 10.1186/s12876-018-0822-y.